Glynamic-Mv 3/0.3MG Tab

Composition

Glimepiride 3 mg + Voglibose 0.3 mg tablet

Uses of Glynamic-Mv 3/0.3MG Tab

Type 2 diabetes mellitus to improve blood glucose control when diet and exercise alone are not adequate; may be used when dual therapy is required for post‑meal and fasting glucose control.

• •Lowers fasting blood sugar
• •Reduces post-meal glucose spikes
• •Improves overall glycaemic control
• •Helps reduce HbA1c when used with diet and exercise

How it works

Glimepiride (a sulfonylurea) increases insulin release from the pancreas and improves insulin sensitivity. Voglibose (an alpha‑glucosidase inhibitor) delays intestinal carbohydrate digestion and absorption, reducing post‑meal blood sugar spikes.

Directions for use

Take orally as prescribed by the doctor, usually once daily with the first main meal (or just before meals as advised). Swallow whole with water; do not skip meals after taking it. Monitor blood glucose regularly.

Side effects

Common side effects of Glynamic-Mv 3/0.3MG Tab may include:

• •Hypoglycaemia
• •dizziness
• •headache
• •nausea
• •abdominal pain
• •flatulence
• •